Erianin, a bibenzyl analog isolated from Dendrobium bulbosum, is also a PD-L1 inhibitor that exhibits potential antitumor activity in a variety of malignant tumors.Erianin regulates a variety of cancer-associated pathways in vitro and in vivo, including apoptosis, cell-cycle arrest, invasion, migration, and autophagy. In addition, Erianin inhibits indoleamine-2,3-dioxygenase (IDO)-induced tumor angiogenesis.
Molekulargewicht:
318.36
Reinheit:
>99%
CAS Nummer:
[95041-90-0]
Target-Kategorie:
PD-1/PD-L1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten